NYSE:CVS

CVS Health Stock Forecast, Price & News

$94.45

-0.09 (-0.10%)

(As of 06/28/2022 11:28 AM ET)

Add

Compare

Today's Range: $94.42
▼
$95.94
50-Day Range: $88.66
▼
$106.64
52-Week Range: $79.33
▼
$111.25

Volume: 89,541 shs
Average Volume: 4.59 million shs
Market Capitalization: $123.85 billion

P/E Ratio: 15.69
Dividend Yield: 2.33%
Price Target: $116.72

30 days | 90 days | 365 days | Advanced Chart

Receive CVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS Health and its competitors with MarketBeat's FREE daily newsletter.

CVS Stock Forecast (MarketRank)

Overall MarketRank^™

2.85 out of 5 stars

Retail/Wholesale Sector

54th out of 283 stocks

Drug Stores & Proprietary Stores Industry

2nd out of 9 stocks

2.4 Analyst's Opinion

Consensus Rating
CVS Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 15 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $116.72, CVS Health has a forecasted upside of 23.5% from its current price of $94.54.
Amount of Analyst Coverage
CVS Health has only been the subject of 2 research reports in the past 90 days.

5.0 Community Rank

Outperform Votes
CVS Health has received 1,356 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
CVS Health has received 394 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
CVS Health has received 77.49% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote “Outperform” if you believe CVS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days.

2.5 Dividend Strength

Dividend Yield
CVS Health pays a meaningful dividend of 2.33%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
CVS Health has only been increasing its dividend for 1 years.
Dividend Coverage
The dividend payout ratio of CVS Health is 36.54%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, CVS Health will have a dividend payout ratio of 24.26% next year. This indicates that CVS Health will be able to sustain or increase its dividend.

2.5 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CVS Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,882,993.00 in company stock.
Percentage Held by Insiders
Only 0.69% of the stock of CVS Health is held by insiders.
Percentage Held by Institutions
78.00% of the stock of CVS Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9 Earnings and Valuation

Earnings Growth
Earnings for CVS Health are expected to grow by 8.75% in the coming year, from $8.34 to $9.07 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of CVS Health is 15.70, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 19.94.
Price to Earnings Ratio vs. Sector
The P/E ratio of CVS Health is 15.70, which means that it is trading at a more expensive P/E ratio than the Retail/Wholesale sector average P/E ratio of about 13.31.
Price to Earnings Growth Ratio
CVS Health has a PEG Ratio of 1.49. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
CVS Health has a P/B Ratio of 1.66. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About CVS Health (NYSE:CVS)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.